25th week of 2020 patent applcation highlights part 28 |
Patent application number | Title | Published |
20200190116 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION | 2020-06-18 |
20200190117 | PROCESS FOR THE PREPARATION OF IXAZOMIB CITRATE | 2020-06-18 |
20200190118 | PROTEASOME INHIBITORS | 2020-06-18 |
20200190119 | SOLID STATE FORMS OF IXAZOMIB CITRATE | 2020-06-18 |
20200190120 | PROCESS FOR THE PREPARATION OF 5-(4-CYANOPHENOXY)-1,3-DIHYDRO-1-HYDROXY-[2,1]-BENZOXABOROLE AND POLYMORPHS THEREOF | 2020-06-18 |
20200190121 | ORGANIC ELECTROLUMINESCENT DEVICES COMPRISING HOST COMPOUNDS | 2020-06-18 |
20200190122 | DELAYED FLUORESCENT COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | 2020-06-18 |
20200190123 | METHOD OF MAKING A HALOSILOXANE | 2020-06-18 |
20200190124 | Luminescent Metal Halide Perovskites and Methods | 2020-06-18 |
20200190125 | Phosphoramidate Compound and Preparation Method and Crystal Thereof | 2020-06-18 |
20200190126 | Inhibitors of Cyclin-Dependent Kinase 7 (CDK7) | 2020-06-18 |
20200190127 | NEW CRYSTAL FORM OF A DITHIOLENE METAL COMPLEX | 2020-06-18 |
20200190128 | METAL COMPLEXES | 2020-06-18 |
20200190129 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | 2020-06-18 |
20200190130 | SIALIDASE INHIBITORS AND PREPARATION THEREOF | 2020-06-18 |
20200190131 | INCLUSION COMPLEXES OF AN HCV NS5B INHIBITOR AND USES THEREOF | 2020-06-18 |
20200190132 | NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA | 2020-06-18 |
20200190133 | CRYSTALLINE SOLVATE FORMS OF A PHARMACEUTICAL | 2020-06-18 |
20200190134 | COMPOUNDS AND METHODS OF MAKING STEROLS USING DIOLS | 2020-06-18 |
20200190135 | LASSO STRUCTURES AND THEIR SYNTHESIS | 2020-06-18 |
20200190136 | METHODS FOR GENERATING SMALL MOLECULE DEGRADERS AND DIMERIZERS | 2020-06-18 |
20200190137 | METHODS FOR PURIFYING PROTEINS | 2020-06-18 |
20200190138 | PROTEIN PURIFICATION WITH PROTEIN L | 2020-06-18 |
20200190139 | Method for purifying proteins using silicate | 2020-06-18 |
20200190140 | NOVEL PEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND USE THEREOF | 2020-06-18 |
20200190141 | PEPTIDE FOR INHIBITING SKIN INFLAMMATION AND COMPOSITION FOR PREVENTING OR TREATING SKIN INFLAMMATION CONTAINING THE SAME | 2020-06-18 |
20200190142 | TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF | 2020-06-18 |
20200190143 | MICROCAPSULE INCLUDING PEPTIDE HAVING CELL RECEPTOR BINDING AFFINITY AND COSMETIC COMPOSITION CONTAINING SAME | 2020-06-18 |
20200190144 | Self-Assembling Peptides Comprising Non-Ionic Polar Amino Acids for Anti-Adhesion | 2020-06-18 |
20200190145 | ANTIMICROBIAL PEPTIDES AND THEIR USE | 2020-06-18 |
20200190146 | METHODS OF DETECTION AND REMOVAL OF RHABDOVIRUSES FROM CELL LINES | 2020-06-18 |
20200190147 | CHIMERIC RECEPTOR BINDING PROTEINS FOR USE IN BACTERIAL DELIVERY VEHICLES | 2020-06-18 |
20200190148 | NANONETS AND SPHERICAL PARTICLES | 2020-06-18 |
20200190149 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | 2020-06-18 |
20200190150 | NOVEL PYRUVATE TRANSPORTER | 2020-06-18 |
20200190151 | KV1.3-BLOCKING VENOM PEPTIDE VARIANTS AND RELATED USES | 2020-06-18 |
20200190152 | Method of Drying Jellyfish Matter | 2020-06-18 |
20200190153 | CONSTITUTIVELY ACTIVE PROFILIN-1 FOR USE IN THE THERAPY AND/OR TREATMENT OF A NEUROLOGICAL DISORDER AND/OR FOR PROMOTING NEURONAL REGENERATION, KIT AND PRODUCTS THEREOF | 2020-06-18 |
20200190154 | FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN | 2020-06-18 |
20200190155 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | 2020-06-18 |
20200190156 | ANTIMICROBIAL AND ANTICANCER PEPTIDES & CONJUGATES AND COMPOSITIONS, METHODS, ARTICLES & KITS RELATING THERETO | 2020-06-18 |
20200190157 | FATTY ACID MODIFIED HUMAN EPIDERMAL GROWTH FACTOR | 2020-06-18 |
20200190158 | RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THERAPEUTIC USES THEREOF | 2020-06-18 |
20200190159 | USE OF TETRANECTIN AND PEPTIDE AGONISTS TO TREAT INFLAMMATORY DISEASES | 2020-06-18 |
20200190160 | PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS | 2020-06-18 |
20200190161 | MUTANT PROTEINS AND METHODS FOR THEIR PRODUCTION | 2020-06-18 |
20200190162 | SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES AND USES THEREOF | 2020-06-18 |
20200190163 | HUMANIZED BCMA-CAR-T CELLS | 2020-06-18 |
20200190164 | MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME | 2020-06-18 |
20200190165 | COMPOUND HAVING AFFINITY SUBSTANCE TO SOLUBLE PROTEIN, CLEAVABLE PORTION AND REACTIVE GROUP, OR SALT THEREOF | 2020-06-18 |
20200190166 | POLYVALENT IMMUNOTHERAPEUTICS OF HIGH SPECIFICTY BASED ON MODIFIED ANTIBODIES AND A LYOPHILIZED INJECTABLE FORMULATION HIGHLY SAFE AND EFFECTIVE | 2020-06-18 |
20200190167 | POLYOMAVIRUS NEUTRALIZING ANTIBODIES | 2020-06-18 |
20200190168 | ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION | 2020-06-18 |
20200190169 | NEUTRALIZING ANTI-INFLUENZA B ANTIBODIES AND USES THEREOF | 2020-06-18 |
20200190170 | BINDING MOIETIES FOR BIOFILM REMEDIATION | 2020-06-18 |
20200190171 | Anti-FSTL3 Antibodies And Uses Thereof | 2020-06-18 |
20200190172 | METHOD FOR DIAGNOSING/DETERMINING THE EFFECTIVENESS OF TREATMENT FOR DEPRESSION | 2020-06-18 |
20200190173 | Immunotherapy for Clearing Pathological Tau Conformers | 2020-06-18 |
20200190174 | SINGLE-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF | 2020-06-18 |
20200190175 | METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 | 2020-06-18 |
20200190176 | FGL2 ANTIBODIES AND BINDING FRAGMENTS THEREOF AND USES THEREOF | 2020-06-18 |
20200190177 | ANTI-TENASCIN C ANTIBODIES AND USES THEREOF | 2020-06-18 |
20200190178 | ANTIBODIES SPECIFIC FOR HYPERPHOSPHORYLATED TAU AND METHODS OF USE THEREOF | 2020-06-18 |
20200190179 | PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY | 2020-06-18 |
20200190180 | IP-10 ANTIBODIES AND THEIR USES | 2020-06-18 |
20200190181 | Method and Compositions for Producing Disulfide-Linked Trimeric TNF Family of Cytokines and Their Use | 2020-06-18 |
20200190182 | IL-33 ANTAGONIST-CONTAINING THERAPEUTIC AGENT FOR ENDOMETRIOSIS | 2020-06-18 |
20200190183 | Method of Treating Cancer with a Cancer Therapy in Combination with Another Therapeutic Agent | 2020-06-18 |
20200190184 | SCREENING METHOD FOR PAIN SUPPRESSOR AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF PAIN | 2020-06-18 |
20200190185 | ANTI-FCRH5 ANTIBODIES | 2020-06-18 |
20200190186 | ANTIBODIES AGAINST TIM3 AND USES THEREOF | 2020-06-18 |
20200190187 | Anti-PD-1 Antibodies | 2020-06-18 |
20200190188 | AGENT, USES AND METHODS FOR TREATMENT | 2020-06-18 |
20200190189 | ANTI-CD3-BINDING DOMAINS AND ANTIBODIES COMPRISING THEM, AND METHODS FOR THEIR GENERATION AND USE | 2020-06-18 |
20200190190 | MODIFIED J-CHAIN | 2020-06-18 |
20200190191 | MULTISPECIFIC ANTIBODY WITH COMBINATION THERAPY FOR IMMUNO-ONCOLOGY | 2020-06-18 |
20200190192 | PD-1/TIM-3 BI-SPECIFIC ANTIBODIES, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME | 2020-06-18 |
20200190193 | PD-1 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF | 2020-06-18 |
20200190194 | COMBINATION THERAPY | 2020-06-18 |
20200190195 | COMBINATION THERAPY WITH ICOS AGONIST AND OX40 AGONIST TO TREAT CANCER | 2020-06-18 |
20200190196 | ANTIBODIES TO B7-H1 | 2020-06-18 |
20200190197 | IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH LIGAND-1 (PD-L1) | 2020-06-18 |
20200190198 | METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR | 2020-06-18 |
20200190199 | ANTIBODY-DRUG CONJUGATES AND USES THEREOF | 2020-06-18 |
20200190200 | Methods of Producing Heterodimeric Antibodies | 2020-06-18 |
20200190201 | TRKB OR TRKC AGONIST COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC CONDITIONS | 2020-06-18 |
20200190202 | Reprogramming of CD8 T Cells with CXCL12 Signaling Inhibitors | 2020-06-18 |
20200190203 | MITIGATION AND REVERSAL OF FIBROSIS AND INFLAMMATION BY INHIBITION OF TL1A FUNCTION AND RELATED SIGNALING PATHWAYS | 2020-06-18 |
20200190204 | BAFF-R ANTIBODIES AND USES THEREOF | 2020-06-18 |
20200190205 | METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICS | 2020-06-18 |
20200190206 | BISPECIFIC ANTIGEN BINDING MOLECULES COMPRISING ANTI-4-1BB CLONE 20H4.9 | 2020-06-18 |
20200190207 | Bispecific antigen binding molecules comprising anti-FAP clone 212 | 2020-06-18 |
20200190208 | NOVEL POLYPEPTIDES | 2020-06-18 |
20200190209 | CD38 MODULATING ANTIBODY | 2020-06-18 |
20200190210 | NEW TARGET FOR TREATING CANCER | 2020-06-18 |
20200190211 | TARGETING GENE AMPLIFICATION IN CANCER USING TRIPLEX FORMATION AS A THERAPEUTIC STRATEGY | 2020-06-18 |
20200190212 | Antibodies binding to STEAP-1 | 2020-06-18 |
20200190213 | TWIN IMMUNE CELL ENGAGER | 2020-06-18 |
20200190214 | TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF | 2020-06-18 |
20200190215 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | 2020-06-18 |